Atossa Genetics Inc. (ATOS) announced Wednesday morning that it has entered into a nationwide distribution agreement with McKesson Medical-Surgical to sell and distribute Atossa's MASCT device and patient collection kits.
Atossa Genetics gapped open higher Wednesday and has spiked to the upside in early trade. The stock is now up 2.45 at $7.41 on the highest volume of the year. Atossa Genetics has surged to a 4 1/2 month high and has re-crossed its 200-day moving average.
For comments and feedback contact: editorial@rttnews.com
Business News